ÂÜÀòÂÒÂ×

Rex Bunnell is a seasoned pharmaceutical professional with extensive experience in oncology sales and account management. Currently serving as a Regional Account Manager at Eagle Pharmaceuticals, Inc. since November 2022, Rex covers Texas, Louisiana, and Oklahoma for the product Pemfexy. Prior to this role, Rex was an Oncology Sales Specialist at MorphoSys, contributing to the successful launch of Monjuvi in the Dallas-Fort Worth area. Rex's background includes significant positions at Bayer, where responsibilities included launching Radium 223 as a Sales Consultant and serving as a Market Development Specialist for Nexavar. Additionally, Rex has a strong training background from a tenure at Abraxis BioScience, overseeing global training for the launch of Abraxane. Rex began a career in pharmaceuticals at Novartis Pharmaceuticals in neuroscience. Rex holds a degree from Angelo State University, obtained between 1987 and 1992.